Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

15

Full text

10

Free full text

4

Publication Types

Journal Article

15

Review

11

Research Support, Non-U.S. Gov't

2

Observational Study

2

Multicenter Study

2

Clinical Trial, Phase III

1

Clinical Trial, Phase II

1

Clinical Trial, Phase I

1

Randomized Controlled Trial

1

Research Support, N.I.H., Extramural

1

Publication Year

From

To

Quick links

Individual year

2025

1

2024

2

2023

2

2022

1

2021

3

2019

1

2018

1

2005

1

2000

3

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Anemia, Hemolytic, Congenital Nonspherocytic""[mesh_terms]

15 Results

Searching titles within these results

Hexokinase: gene structure and mutations.

H Kanno

Bailliere's best practice & research. Clinical haematology 2000;13(1):83-8

Red Blood Cell Enzyme Disorders.

Rachael F Grace, Bertil Glader

Pediatric clinics of North America 2018;65(3):579-595

Molecular heterogeneity of pyruvate kinase deficiency.

Elisa Fermo, Paola Bianchi

Haematologica 2021;105(9):2218-2228

Diagnosis, monitoring, and management of pyruvate kinase deficiency in children.

Rachael F Grace, Jenny M Despotovic, Shaniqua Johnson

Pediatric blood & cancer 2022;69(8):e29696

Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.

P Bianchi, A Zanella

Bailliere's best practice & research. Clinical haematology 2000;13(1):57-81

How we manage patients with pyruvate kinase deficiency.

Rachael F Grace, D Mark Layton, Wilma Barcellini

British journal of haematology 2019;184(5):721-734

Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency.

Erin Zagadailov, Hanny Al-Samkari, Audra N Boscoe, Bryan McGee, Sherry Shi, Dendy Macaulay, Lizheng Shi, Viviana Garcia-Horton

Hematology (Amsterdam, Netherlands) 2023;29(1):2290746

Mitapivat for sickle cell disease and thalassemia.

Federica Pilo, Emanuele Angelucci

Drugs of today (Barcelona, Spain : 1998) 2023;59(3):125-134

Glucose-6-phosphate dehydrogenase deficiency.

A Mehta, P J Mason, T J Vulliamy

Bailliere's best practice & research. Clinical haematology 2000;13(1):21-38

Hereditary disorders of ineffective erythropoiesis.

Richard A King, Rami Khoriaty

Blood cells, molecules & diseases 2025;111():102910

Laboratory approach to investigation of anemia with a focus on pyruvate kinase deficiency.

Anton Rets, Archana M Agarwal

International journal of laboratory hematology 2021;42 Suppl 1():107-112

Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.

Melissa DiBacco, Rachael F Grace, Andreas Glenthøj, Eduard J van Beers, Megan Wind-Rotolo, Wilma Barcellini, Kevin H M Kuo, Hanny Al-Samkari, John B Porter, Rengyi Xu, Vanessa Beynon, Parija Patel

Blood advances 2024;8(10):2433-2441

Red cell pyruvate kinase deficiency: molecular and clinical aspects.

Alberto Zanella, Elisa Fermo, Paola Bianchi, Giovanna Valentini

British journal of haematology 2005;130(1):11-25

Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry.

Carl Lander, Audra N Boscoe, Junlong Li, Rachael F Grace, Bertil Glader, Andreas Glenthøj, Bryan McGee, Eduard J van Beers, Paola Bianchi, Kevin H M Kuo, Yan Yan

British journal of haematology 2024;205(2):613-623

Management of pyruvate kinase deficiency in children and adults.

Rachael F Grace, Wilma Barcellini

Blood 2021;136(11):1241-1249

Results: 1 – 15 / 15

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.